Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Meta-regression results

From: The Role of Aerobic Training Variables Progression on Glycemic Control of Patients with Type 2 Diabetes: a Systematic Review with Meta-analysis

Moderator Number of study estimates Β 95% CI p value R 2
Progressive aerobic training
 Mean age 14 0.045 − 0.074; 0.166 0.457 0.00
 Percentage of women in the sample 10 − 0.007 − 0.056; 0.041 0.765 0.00
 Body mass index 13 − 0.737 − 1.346; − 0.128 0.017 0.20
 Diagnosis duration 11 0.076 −0.069; 0.223 0.303 0.00
 Baseline HbA1c 10 0.009 −1.508; 1.318 0.895 0.00
 Glucose lowering drug users 5 − 0.080 − 0.113; − 0.046 < 0.001 1.00
 Follow-up duration 14 − 0.088 − 0.147; − 0.029 0.003 0.37
 Weekly frequency 14 − 0.426 − 1.677; 0.825 0.504 0.00
 Session duration 13 − 0.005 − 0.055; 0.043 0.820 0.00
 Weekly duration 13 0.001 − 0.016; 0.017 0.960 0.00
Non-progressive aerobic training
 Mean age 12 0.001 − 0.001; 0.002 0.442 0.00
 Percentage of women in the sample 10 0.003 − 0.013; 0.021 0.662 0.00
 Body mass índex 12 0.096 − 0.039; 0.232 0.163 0.00
 Diagnosis duration 10 − 0.015 − 0.449; 0.417 0.942 0.00
 Baseline HbA1c 12 − 0.229 − 0.898; 0.440 0.502 0.06
 Glucose lowering drug users 8 − 0.027 − 0.099; 0.045 0.462 0.00
 Follow-up duration 13 0.005 − 0.046; 0.056 0.846 0.00
 Session duration 13 − 0.026 − 0.058; 0.007 0.128 0.09
 Weekly frequency 13 − 0.536 − 0.904; − 0.168 0.004 0.38
 Weekly duration 13 − 0.005 − 0.010; − 0.001 0.020 0.27
  1. Numbers in italic indicate statistical significance (p < 0.05)